MCAP MediaWire·2 days ago
�Nephros Announces Inclusion in the Russell Microcap® IndexPR Audio: SOUTH ORANGE, NJ, July 6, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Nephros, Inc.
Nephros, Inc.(NEPH)Earnings, Financials & Key Ratios
NEPH•NASDAQ
$3.41
31.0× P/E·Price updated Jul 7, 2026
AboutNephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also develops and sells real-time water testing systems to provide actionable data on waterborne pathogens; and medical device products for patients with renal disease, including a 2nd generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it offers water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and AETHER brands for the food service, hospitality, convenience store, and health care markets. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.Show more
- Revenue$19M+32.7%
- EBITDA$1M+799.3%
- Net Income$1M+1513.5%
- EPS (Diluted)0.11+1471.4%
- Gross Margin61.13%-0.8%
- EBITDA Margin6.84%+577.9%
- Operating Margin6.1%+14285.1%
- Net Margin6.35%+1116.2%
- ROE12.71%+1355.2%
NEPH Price & Volume
Nephros, Inc. (NEPH) stock price & volume — 10-year historical chart
Loading chart...
Volatile Revenue Growth Masks Operational Margin Challenges
Investment Thesis • Updated 2026Q1
VerdictNeutral
Growth:Mixed
Profitability:Strained
Financial:Healthy
Cash Flow:Mixed
Primary Risk:Operating scale and liquidity
Key Thesis Takeaways
- Nephros demonstrates a specialized value proposition in medical filtration with gross margins peaking at 64.7%, yet the firm struggles to achieve consistent operating leverage as SG&A expenses frequently exceed $2.0 million per quarter.
- While the balance sheet remains healthy with a conservative 0.09 debt-to-equity ratio, the company's reliance on lumpy hospital rollouts creates significant top-line volatility.
- Investors should monitor the firm's ability to stabilize cash conversion, as evidenced by the recent swing to a $1.7 million cash burn in 2026Q1.
Verdict Logic
while the company maintains a strong liquidity position with $4.0 million in cash, the inconsistent free cash flow trajectory and the $143 million accumulated deficit warrant a cautious approach until operating scale is achieved.
NEPH Growth Metrics
Nephros, Inc. (NEPH) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years25.46%
5 Years17.02%
3 Years23.5%
TTM23.25%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-3.12%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-6.49%
Return on Capital
10 Years-39.49%
5 Years-12.04%
3 Years-1.75%
Last Year11.17%
Latest NEPH News
Recent stock market news and headlines for Nephros, Inc. (NEPH)
GlobeNewsWire·2 days ago
Nephros Announces Inclusion in the Russell Microcap® IndexSOUTH ORANGE, N.J., July 06, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that the company has been added to the Russell Microcap® Index at the conclusion of the 2026 annual reconstitution.
MCAP MediaWire·Jun 18, 2026
Nephros to Host Virtual Investor Event: “Beyond Filtration: The Nephros Model in Action”SOUTH ORANGE, N.J., June 18, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will host a virtual investor event titled, “Beyond Filtration: The Nephros Model in Action” on July 16th, 2026.
GlobeNewsWire·Jun 18, 2026
Nephros to Host Virtual Investor Event: “Beyond Filtration: The Nephros Model in Action”SOUTH ORANGE, N.J., June 18, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will host a virtual investor event titled, “Beyond Filtration: The Nephros Model in Action” on July 16th, 2026.
Globe News Wire·Jun 16, 2026
Nephros Positions Ultrafiltration Technology as a Solution to Emerging Microplastic Risk in WaterFollows U. S. EPA's April 2026 decision to include microplastics as a priority contaminant group under the Safe Drinking Water Act's draft Contaminant Candidate List Company underscores relevance of advanced filtration in addressing one of the fastest-growing concerns in water quality SOUTH ORANGE, N.
Peers Comparison
Key metrics vs top competitors for Nephros, Inc. (NEPH)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $3.41 | $37.02M | 31.00 | 32.67% | 6.35% | 12.71% | — | |
| $34.24 | $1.06B | 22.68 | 5.16% | 4% | 5.4% | — | |
| $17.72 | $2.02B | -14.52 | 8.28% | -25.66% | -50.82% | — | |
| $13.07 | $540.04M | -15.75 | -3.76% | -10% | -17.65% | — | |
| $16.60 | $762.4M | -3.06 | 43.81% | -13.85% | -35.45% | — | |
| $102.77 | $4.54B | 31.62 | 5.44% | 6.91% | 11.44% | — |
Compare NEPH vs Peers
Nephros, Inc. (NEPH) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
NEPH SEC Filings & Documents
Nephros, Inc. (NEPH) SEC filings — annual & quarterly reports (10-K, 10-Q)
8-K Announcements
6Material company update
May 7, 2026·SEC
Material company update
Mar 27, 2026·SEC
Material company update
Nov 26, 2025·SEC
10-K Annual Reports
410-Q Quarterly Reports
6Get notified when NEPH posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
NEPH Frequently Asked Questions
Nephros, Inc. (NEPH) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Nephros, Inc.'s revenue?
Nephros, Inc. (NEPH) reported $19.1M in revenue for fiscal year 2025.
How fast is Nephros, Inc. growing?
Nephros, Inc. (NEPH) grew revenue by 32.7% over the past year. This is strong growth.
Is NEPH profitable?
Yes, Nephros, Inc. (NEPH) is profitable, generating $0.8M in net income for fiscal year 2025 (6.4% net margin).
Dividend & Returns
What is NEPH's return on equity?
Nephros, Inc. (NEPH) has a return on equity (ROE) of 12.7%. This is reasonable for most industries.
What is Nephros, Inc.'s free cash flow?
Nephros, Inc. (NEPH) had negative free cash flow of $0.3M in fiscal year 2025, likely due to heavy capital investments.